Steward Health Care Chairman and CEO Ralph de la Torre, MD, has "amicably separated" from the system, effective Oct. 1, a Steward spokesperson confirmed to Becker's .

Toby Cosgrove, former CEO of Cleveland Clinic and Kyle Kiser, CEO of Arrive Health, discuss changes in healthcare, aiming to improve patient affordability. Rising drug costs and lack of cost ...

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations ...

Financial pressures continue to mount for healthcare supply chain leaders as the industry transitions from the traditional fee-for-service payment model to new models driven by value-based care.

Norfolk, Va.-based Sentara Health is cutting about 200 positions, with a majority of the cuts coming from its health plan division.

CEO Dr. Jawad Shah has grown Insight Health System from a small physician office into a multistate hospital system.

Learn about the recent ransomware attack on a Texas health system and how it is impacting patient care. Stay informed with these six key details.

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates ...

President Biden and Vice President Kamala Harris were joined by survivors of gun violence, local and state officials and advocates at the White House for the signing ceremony. Among them was Chethan ...

Monique Díaz, MD, will assume the role of vice president and regional chief medical information officer for CommonSpirit Health's California region, according to her LinkedIn.

Learn from a healthcare executive how to lead through a crisis and prioritize checking in with your team. Insights from Jon Sendach of Northwell Health.

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...